Paxil Generics Grab 65% Of New Scripts; Apotex May Sue Over Par/GSK Deal
Executive Summary
Generics of GlaxoSmithKline's antidepressant Paxil have captured 65% of the market for new paroxetine prescriptions, Apotex said
You may also be interested in...
GSK Is Not Aventis’ “White Knight”; 2004 Will Be A Transition Year
GlaxoSmithKline will not make a "white knight" bid for Aventis, GSK said during its Feb. 12 year-end earnings presentation
GSK Is Not Aventis’ “White Knight”; 2004 Will Be A Transition Year
GlaxoSmithKline will not make a "white knight" bid for Aventis, GSK said during its Feb. 12 year-end earnings presentation
Synthon Pexeva To Launch At 20% Discount To Generic Paxil; GSK Suit Settled
Synthon will launch Pexeva (paroxetine mesylate) during the first half of the year at a 20% discount to generic versions of Paxil (paroxetine hydrochloride)